Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer
Elastin-like polypeptides (ELP) are versatile protein biopolymers used in drug delivery due to their modular nature, allowing fusion of therapeutics and targeting agents. We previously developed an ELP fusion with vascular endothelial growth factor (VEGF) and demonstrated its therapeutic efficacy in...
Main Authors: | Fakhri Mahdi, Alejandro R. Chade, Gene L. Bidwell |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/10/542 |
Similar Items
-
Investigation of Ion-Peptide Interactions Using a Biocompatible Nanopore Probe
by: Bard, Sean
Published: (2012) -
Optimization of PET Expression Vector for Fusion of Recombinant Protein and Elastin-Like Polypeptide Biopolymer
by: Mohammad Reza Soleyman, et al.
Published: (2019-11-01) -
Application of Thermally Responsive Elastin-like Polypeptide Fused to a Lactoferrin-derived Peptide for Treatment of Pancreatic Cancer
by: Emily Thomas, et al.
Published: (2009-06-01) -
Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes
by: Amiram, Miriam
Published: (2012) -
Cell-Penetrating Doxorubicin Released from Elastin-Like Polypeptide Kills Doxorubicin-Resistant Cancer Cells in In Vitro Study
by: Jung Su Ryu, et al.
Published: (2021-01-01)